Chemomab Therapeutics Ltd. (CMMB) Ownership
CMMB ownership summary
as of October 18, 2026- Institutions
- 19.1% of shares outstanding
- Insiders
- 12.19% of shares outstanding
- Shares outstanding
- 7.3M
- Float
- 6.1M shares available to trade
- Short interest
- 0.15% 11K shares short
- Days to cover
- 0.07 short interest down 87.1% vs prior month
- Institutions 19.13%
- Insiders 12.19%
- Other investors 68.68%
CMMB top institutional holders
1 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Advisory Services Network, LLC | 0.00% | — | — | −4,786 (−100.0%) | March 31, 2024 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 1, 0 holders added 0 shares and 1 cut 4,786.
CMMB top mutual fund and ETF holders
1 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | HBM Healthcare Investments AG Ord | 2.13% | 228K | $287,788 | — | June 30, 2026 |
Funds report holdings monthly or quarterly; dates differ by fund.
CMMB insider transactions
latest 3| Date | Name | Transaction | Price | Shares | Value |
|---|---|---|---|---|---|
| 2023-01-03 | Israel Gp Ltd. Orbimed | Sell | $14.32 | 84,225 | $1.2M |
| 2022-11-16 | George Adi Mor | Sell | $8.32 | 81,193 | $675,526 |
| 2022-11-16 | Neil Harris Cohen | Sell | $8.00 | 602 | $4,816 |
Reported trades by company officers, directors and other filers (including disclosures by members of Congress where EODHD lists them). "—" where the filing gives no share count.
CMMB shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns CMMB
Institutional investors own 19.1% of Chemomab Therapeutics's shares and insiders 12.19%. The largest holder is Advisory Services Network, LLC with 0.00% of the shares (0), as of March 31, 2024. Among the top 1 institutions, 0 added shares and 1 reduced their stake in the latest filings. Short interest is 0.15% of the float, or 0.07 days of average trading volume. The share count rose 2,013.8% since 2016.
Related: CMMB analyst forecast, CMMB key metrics. See the CMMB stock overview for the latest quote and news.
CMMB ownership FAQ
Who owns the most Chemomab Therapeutics stock?
The largest shareholders of Chemomab Therapeutics are Advisory Services Network, LLC (0.00%).
What percentage of Chemomab Therapeutics is owned by institutions?
Institutions hold 19.1% of Chemomab Therapeutics's shares outstanding; insiders hold 12.19%.
Which funds own Chemomab Therapeutics?
The largest fund holders of Chemomab Therapeutics are HBM Healthcare Investments AG Ord (2.13%).
What is Chemomab Therapeutics's short interest?
11K shares of Chemomab Therapeutics were sold short, 0.15% of the float; at the average daily volume it would take 0.07 days to cover.
Are insiders buying or selling Chemomab Therapeutics?
Of the latest 3 reported insider transactions in Chemomab Therapeutics (since November 16, 2022), 0 were purchases and 3 were sales.
How many shares of Chemomab Therapeutics are outstanding?
Chemomab Therapeutics has 7.3M shares outstanding, of which 6.1M are in the public float.